CoChat

The DOI matches its Crossref record; the references it cites are not checked yet.

Nasal methicillin-resistant staphylococcus aureus (MRSA) PCR testing reduces the duration of MRSA-targeted therapy in patients with suspected MRSA pneumonia.

Open access
Baby, Nidhu, Faust, Andrew C., Smith, Terri, Sheperd, Lyndsay A., Knoll, Laura, Goodman, Edward L. · 2017 · Antimicrobial Agents and Chemotherapy

Abstract

The objective of this study was to evaluate the impact of pharmacist-ordered methicillin-resistant Staphylococcus aureus(MRSA) PCR testing on the duration of empirical MRSA-targeted antibiotic therapy in patients with suspected pneumonia. This is a retrospective analysis of patients who received vancomycin or linezolid for suspected pneumonia before and after the implementation of a pharmacist-driven protocol for nasal MRSA PCR testing. Patients were included if they were adults of >18 years of age and initiated on vancomycin or linezolid for suspected MRSA pneumonia. The primary endpoint was the duration of vancomycin or linezolid therapy. After screening 368 patients, 57 patients met inclusion criteria (27 pre-PCR and 30 post-PCR). Baseline characteristics were similar between the two groups, with the majority of patients classified as having health care-associated pneumonia (68.4%). The use of the nasal MRSA PCR test reduced the mean duration of MRSA-targeted therapy by 46.6 h (74.0 ± 48.9 h versus 27.4 ± 18.7 h; 95% confidence interval [CI], 27.3 to 65.8 h;P< 0.0001). Fewer patients in the post-PCR group required vancomycin serum levels and dose adjustment (48.1% versus 16.7%;P= 0.02). There were no significant differences between the pre- and post-PCR groups regarding days to clinical improvement (1.78 ± 2.52 versus 2.27 ± 3.34;P= 0.54), length of hospital stay (11.04 ± 9.5 versus 8.2 ± 7.8;P= 0.22), or hospital mortality (14.8% versus 6.7%;P= 0.41). The use of nasal MRSA PCR testing in patients with suspected MRSA pneumonia reduced the duration of empirical MRSA-targeted therapy by approximately 2 days without increasing adverse clinical outcomes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/aac.02432-16

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

The citation lists are queued

They are fetched later and appear here then.

References 20 · Cited by 94

Research works printed but not linked: 1

  1. 10.1001/jama.1993.03510240069035 · DOI · Paper page

Metadata

Authors
Baby, N., Faust, A. C., Smith, T., Sheperd, L. A., Knoll, L., & Goodman, E. L.
Affiliations
  • Texas Tech University (US)
  • Texas Health Dallas (US)
Venue
Antimicrobial Agents and Chemotherapy
Published
2017-04
Volume
61
Issue
4
ISSN
  • 0066-4804 (ISSN-L)
  • 1098-6596
OpenAlex
W2580351979
Cited by
94
References
20
Citations by year
2026: 8 · 2025: 8 · 2024: 10 · 2023: 12 · 2022: 8 · 2021: 17 · 2020: 8 · 2019: 9 · 2018: 10 · 2017: 4
FWCI
6.53
Type
journal article
Language
en
Open access
Licence
journals.asm.org/non-commercial-tdm-license (tdm)
Locations
  • Antimicrobial Agents and Chemotherapy (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
  • Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
  • Health Sciences › Medicine › Microbiology (medical) › Bacterial Identification and Susceptibility Testing
Keywords
methicillin-resistant Staphylococcus aureus, MRSA pneumonia, vancomycin, linezolid, healthcare-associated pneumonia, length of hospital stay
MeSH terms
Aged, Aged, 80 and over, Anti-Bacterial Agents, Female, Humans, Male, Middle Aged, Nose, Pneumonia, Staphylococcal, Retrospective Studies, Time Factors, Vancomycin, Polymerase Chain Reaction, Methicillin-Resistant Staphylococcus aureus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Nasal methicillin-resistant staphylococcus aureus (MRSA) PCR testing reduces the duration of MRSA-targeted therapy in patients with suspected MRSA pneumonia. https://app.cochat.ai/papers/10.1128/aac.02432-16
The paper
Baby, N., Faust, A. C., Smith, T., Sheperd, L. A., Knoll, L., & Goodman, E. L. (2017). Nasal methicillin-resistant staphylococcus aureus (MRSA) PCR testing reduces the duration of MRSA-targeted therapy in patients with suspected MRSA pneumonia. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.02432-16

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.